Orgenesis Inc.
ORGS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $530 | $36,025 | $35,502 | $7,652 |
| % Growth | -98.5% | 1.5% | 364% | – |
| Cost of Goods Sold | $6,255 | $20,440 | $28,160 | $31,099 |
| Gross Profit | -$5,725 | $15,585 | $7,342 | -$23,447 |
| % Margin | -1,080.2% | 43.3% | 20.7% | -306.4% |
| R&D Expenses | $11,087 | $6,010 | $36,644 | $83,986 |
| G&A Expenses | $34,624 | $16,155 | $15,397 | $19,353 |
| SG&A Expenses | $34,624 | $16,155 | $14,710 | $18,973 |
| Sales & Mktg Exp. | $0 | $0 | -$687 | -$380 |
| Other Operating Expenses | $2,200 | $788 | -$1,330 | $474 |
| Operating Expenses | $47,911 | $22,953 | $50,024 | $103,433 |
| Operating Income | -$53,636 | -$7,541 | -$16,800 | -$95,781 |
| % Margin | -10,120% | -20.9% | -47.3% | -1,251.7% |
| Other Income/Exp. Net | -$10,809 | -$4,419 | -$1,151 | -$951 |
| Pre-Tax Income | -$64,445 | -$11,960 | -$17,951 | -$96,736 |
| Tax Expense | $473 | $209 | $108 | -$1,609 |
| Net Income | -$55,361 | -$14,889 | -$18,059 | -$95,808 |
| % Margin | -10,445.5% | -41.3% | -50.9% | -1,252.1% |
| EPS | -1.91 | -0.59 | -0.74 | -4.46 |
| % Growth | -223.7% | 20.3% | 83.4% | – |
| EPS Diluted | -1.91 | -0.59 | -0.74 | -4.46 |
| Weighted Avg Shares Out | 29,008 | 25,096 | 24,274 | 21,320 |
| Weighted Avg Shares Out Dil | 29,008 | 25,096 | 24,274 | 21,320 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,824 | $0 | $0 |
| Interest Expense | $2,167 | $1,824 | $369 | $1,094 |
| Depreciation & Amortization | $1,560 | $1,978 | $1,864 | $1,435 |
| EBITDA | -$60,718 | -$8,158 | -$15,718 | -$94,207 |
| % Margin | -11,456.2% | -22.6% | -44.3% | -1,231.1% |